Further Characterization of the Antiviral Transmembrane Protein MARCH8

Area of Science:

• Virology
• Cell Biology
• Immunology

Background:

• MARCH8 is a cellular transmembrane protein known to downregulate viral envelope glycoproteins.
• This downregulation by MARCH8 reduces the efficiency of viral infection by limiting glycoprotein incorporation into virions.

Purpose of the Study:

• To characterize the species specificity of MARCH8's antiviral activity.
• To identify the specific domains within MARCH8 responsible for its antiviral function.
• To assess MARCH8's efficacy in inhibiting cell-to-cell HIV-1 infection.

Main Methods:

• Investigated species specificity of MARCH8 using rhesus macaque, mouse, and bovine versions.
• Analyzed functional importance of RING-CH domains and tyrosine motifs.
• Constructed chimeric proteins between MARCH8 and MARCH3 to map critical domains.
• Assessed inhibition of HIV-1 Env and VSV-G pseudovirus infection.
• Evaluated inhibition of cell-to-cell HIV-1 infection.

Main Results:

• The antiviral function of MARCH8 is conserved across rhesus macaque, mouse, and bovine species.
• RING-CH domains are essential for inhibiting HIV-1 Env and VSV-G pseudovirus infection.
• Tyrosine motifs are critical for inhibiting HIV-1 Env but not VSV-G.
• Both N-terminal and C-terminal cytoplasmic tails, and the N-terminal transmembrane domain, are crucial for antiviral activity.
• MARCH8 does not inhibit cell-to-cell HIV-1 infection due to insufficient Env downregulation.

Conclusions:

• MARCH8 exhibits conserved antiviral properties across multiple species.
• Specific domains, including RING-CH and cytoplasmic tails, are critical for MARCH8's antiviral mechanism.
• MARCH8's inability to block cell-to-cell spread highlights limitations in its broad antiviral capacity against HIV-1.